John A Gruner Selected Research

sidnocarb (mesocarb)

5/2011

Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John A Gruner Research Topics

Disease

2	Disorders of Excessive Somnolence (Hypersomnia) 05/2011 - 11/2009
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2019
1	Epilepsy (Aura) 01/2019
1	Sleep Wake Disorders 01/2016
1	Schizophrenia (Dementia Praecox) 01/2012

Drug/Important Bio-Agent (IBA)

1	ganaxoloneIBA 01/2019
1	Pregnanolone (Allopregnanolone)IBA 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	LithiumIBA 01/2019
1	Diazepam (Valium)FDA LinkGeneric 01/2019
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	3- (1'- cyclobutylspiro(4H- 1,3- benzodioxine- 2,4'- piperidine)- 6- yl)- 5,5- dimethyl- 1,4- dihydropyridazin- 6- oneIBA 01/2016
1	6- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- oneIBA 01/2012
1	Antipsychotic Agents (Antipsychotics)IBA 01/2012
1	sidnocarb (mesocarb)IBA 05/2011
1	Dopamine Agents (Dopaminergic Agents)IBA 11/2009
1	Dopamine (Intropin)FDA LinkGeneric 11/2009
1	Wakefulness-Promoting AgentsIBA 11/2009

Therapy/Procedure

1	Therapeutics 01/2012